
 Rapid tests for fluoroquinolone, erythromycin, lincomycin, tillosin and tilmycosin residues in milk, whey
Rapid tests for fluoroquinolone, erythromycin, lincomycin, tillosin and tilmycosin residues in milk, whey PIONEER MEIZHENG BIO-TECH (5 in1) JC1165 / Rapid tests for the determination of the residual amount of halofuginone, flavomycin, novobiocin, flunixin, dexamethasone / prednisolone in milk, whey
PIONEER MEIZHENG BIO-TECH (5 in1) JC1165 / Rapid tests for the determination of the residual amount of halofuginone, flavomycin, novobiocin, flunixin, dexamethasone / prednisolone in milk, wheyIn Moscow, 11 children participating in a clinical trial received the first dose of the adapted Sputnik V coronavirus vaccine, the chief physician of the Children's City Clinical Hospital named after V.I. PER. Bashlyaeva Ismail Osmanov on the air of the RUSSIA 24 TV channel.
In a conversation with RBC, he clarified that a total of 100 children are participating in the study.
“Children first underwent a serious selection among hundreds of other volunteers, went to our clinic, where we completely examined them, excluded all possible contraindications. Yesterday we hospitalized them, examined them, today we have already vaccinated them,” Osmanov said.
According to him, the vaccinated will be allowed to go home on the fourth day from the moment of receipt, and in three weeks they will return for vaccination with the second component.
“And during the year we will monitor and carefully observe them. All this is being done jointly with the Gamaleya Institute,” the HEAD physician added.
Tests of "Sputnik V" on teenagers began in Moscow Society
In July, studies of the Sputnik V vaccine adapted for children aged 12 to 17 began in Moscow. The first and second phases will be held on the basis of two children's hospitals - the Morozov Children's Hospital and the Children's Hospital. PER. Bashlyaeva. 100 people have already been selected. They will be given Sputnik V at a lower dose.
The third phase of the research, which will take place in children's clinics in Moscow, will involve 250 people, volunteers will begin to be selected at the end of this summer. The research will last one year.
Chief freelance specialist in pediatric hematology of the Ministry of HEALTH, DIRECTOR of the Center. Dmitry Rogachev Alexander Rumyantsev ruled out risks for adolescents participating in the studies. Participants will receive a reduced dose of the vaccine, and the studies themselves are being conducted in two metropolitan hospitals "in a very tightly regulated version," he said. Children who have no contraindications were selected for participation.
Spread of coronavirus covid-19 in the regions of Russia July 6 Number of confirmed cases of infection <1000 0 <20,000 0 <40,000 0 <60,000 0 from 60,000 0 Created with Highmaps 5.0.100500k1 000k1 500kZoom in+Zoom out- regional headquarters for the fight against the virus Data for Russia i